Sumitomo Dainippon Pharma Annual Report 2017
79/102

Thousands of U.S. dollars $ —————$ ——————1,867232$ 2,099$ —DifferenceFair values$ 637,58023,839973,473150,170651,607$ 2,436,669946450,11613,339357,14378,732180,43871,661$ 1,152,375$ (277)Book values$ 637,58023,839973,473150,170651,607$ 2,436,669946450,11613,339357,14378,732178,57171,429$ 1,150,276$ (277)2017(1) Cash and time deposits (2) Trade notes (3) Trade accounts (4) Due from parent company, unconsolidated subsidiaries and afliates(5) Marketable securities and investment securities Total assets(1) Trade notes(2) Trade accounts(3) Due to parent company, unconsolidated subsidiaries and afliates(4) Short-term loans payable(5) Income taxes payable(6) Bonds payable (*1)(7) Long-term loans payable (*2) Total liabilities Derivative transactions(*1) Bonds payable include the amount of current portion of long-term bonds payable.(*2) Long-term loans payable are the amount of current portion of long-term loans payable.Millions of yen¥ —————¥ —————39075¥ 465¥ —¥ —DifferenceFair values¥ 54,9232,512105,31648,513132,683¥ 343,9479342,4361,1111,01026,35830,39020,075¥ 121,473¥ 181Book values¥ 54,9232,512105,31648,513132,683¥ 343,9479342,4361,1111,01026,35830,00020,000¥ 121,008¥ 1812016(1) Cash and time deposits(2) Trade notes(3) Trade accounts(4) Due from parent company, unconsolidated subsidiaries and afliates(5) Marketable securities and investment securities Total assets(1) Trade notes(2) Trade accounts(3) Due to parent company, unconsolidated subsidiaries and afliates(4) Short-term loans payable(5) Income taxes payable(6) Bonds payable (*1)(7) Long-term loans payable (*2) Total liabilities Derivative transactions(*1) Bonds payable include the amount of current portion of long-term bonds payable.(*2) Long-term loans payable include the amount of current portion of long-term loans payable.78Sumitomo Dainippon Pharma Co., Ltd. Annual Report 2017

元のページ  ../index.html#79

このブックを見る